Table 2.
Resource use description showing the proportion of individuals who were on medication and the number of laboratory tests performed during the study follow-up
| Resource | HIV | Diabetes | Hypertension | HIV + diabetes | HIV + hypertension | Diabetes + hypertension | HIV + diabetes + hypertension |
|---|---|---|---|---|---|---|---|
| Number at study end | 795 | 288 | 537 | 44 | 245 | 316 | 48 |
| Medication,n (%) | |||||||
| No medication | 76 (9.6%) | 31 (10.8%) | 49 (9.1%) | 1 (2.3%) | 18 (7.3%) | 14 (4.4%) | 1 (2.1%) |
| On medication | 719 (90.4%) | Overall, 257 (89.2%) | Overall, 488 (90.9%) | Both drugs, 29 (65.9%) | Both drugs, 131 (53.5%) | Both drugs, 239 (75.6%) | All drugs, 26 (54.2%) |
| 1 drug, 104 (36.1%) | 1 drug, 115 (21.4%) | ART only, 10 (22.7%) | ART only, 87 (35.5%) | Diabetic only, 40 (12.7%) | ART only, 8 (16.7%) | ||
| 2 drugs, 144 (50.0%) | 2 drugs, 282 (52.5%) | Diabetic only, 4 (9.1%) | Hypertensive only, 9 (3.7%) | Hypertensive only, 23 (7.3%) | Diabetic only, 1 (2.1%) | ||
| 3 drugs, 9 (3.1%) | 3 drugs, 91 (17.0%) | Hypertensive only, 2 (4.2%) | |||||
| ART and diabetic, 6 (12.5%) | |||||||
| ART and hypertensive, 3 (6.3%) | |||||||
| Hypertensive and diabetic, 1 (2.1%) | |||||||
| Diagnostics,n (%)a | |||||||
| Viral load test | 597 (75.1) | 0 (0.0) | 0 (0.0) | 34 (77.3) | 160 (65.3) | 0 (0.0) | 31 (64.6) |
| CD4 count test | 87 (10.9) | 0 (0.0) | 0 (0.0) | 2 (4.5) | 23 (9.4) | 0 (0.0) | 3 (6.3) |
| HbA1c test | 7 (0.9) | 171 (59.4) | 4 (0.7) | 22 (50.0) | 2 (0.8) | 130 (41.1) | 22 (45.8) |
| Fasting blood sugar test | 33 (4.2) | 273 (94.8) | 45 (8.4) | 34 (77.3) | 10 (4.1) | 300 (94.9) | 42 (87.5) |
| Random blood sugar test | 48 (6.0) | 104 (36.1) | 42 (7.8) | 13 (29.5) | 12 (4.9) | 130 (41.1) | 16 (33.3) |
| Haemoglobin test | 41 (5.2) | 7 (2.4) | 5 (0.9) | 2 (4.5) | 12 (4.9) | 2 (0.6) | 3 (6.3) |
| Cholesterol test | 6 (0.8) | 34 (11.8) | 28 (5.2) | 2 (4.5) | 6 (2.4) | 26 (8.2) | 1 (2.1) |
| Creatinine test | 14 (1.8) | 25 (8.7) | 19 (3.5) | 3 (6.8) | 4 (1.6) | 22 (7.0) | 1 (2.1) |
| Urine test | 7 (0.9) | 11 (3.8) | 15 (2.8) | 2 (4.5) | 5 (2.0) | 17 (5.4) | 2 (4.2) |
| Renal and liver function test | 4 (0.5) | 16 (5.6) | 20 (3.7) | 3 (6.7) | 13 (6.1) | 41 (13.0) | 3 (6.3) |
| Other testsb | 73 (9.2) | 63 (21.9) | 62 (11.5) | 14 (31.1) | 43 (20.2) | 62 (19.7) | 6 (12.5) |
aNumber of patients with at least a test performed during the follow-up period
bOther tests include tests such as pregnancy test, syphilis, malaria test, etc.